ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

NCI, CDC To Collaborate On Surveillance System.

March 24, 2000

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

Funding opportunities listed.

May 28, 2004